Hashimoto's thyroiditis (HT) is an autoimmune disease of the thyroid associated with goiter and hypothyroidism. Although there exists a clear association between HT and lymphomas of the thyroid, the association between HT and thyroid cancer remains unclear. To evaluate this further, we retrospectively reviewed the pathology reports for all thyroidectomy specimens as well as the records of patients admitted to the University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A., over a 10-yearperiod (1975-1985) with the diagnosis of HT or chronic lymphocytic thyroiditis (CLT). Eight hundred and nine pathologic diagnoses were recorded for 816 thyroidectomy specimens from 793 patients. Furthermore, 180 of 228 patient chart records were available for review. Only 128 patients satisfied our criteria for the diagnosis of HT. HT or CLT were diagnosed in 147 (18.2%) of 809 thyroid specimens. HT occurred concurrently with thyroid cancer in 24% of all cases of HT, whereas, HT occurred concurrently with benign thyroid disease in 71% of all cases of HT in all thyroid specimens. Furthermore, HT was associated with 43 (22%) of 195 cases of thyroid cancer. There were 111 (87%) women and 17 (13%) men of 128 patients whose charts were reviewed. The mean age was 49 -+ 14 years. Ninety-eight (77%) of the patients presented with goiters and 57 (45%) presented with dominant thyroid masses, 38 (67%) of which were solitary nodules. One patient (0.8%) presented with a recurrent laryngeal nerve palsy (RLNP) and 12 (9%) presented with tracheal compression. Only 29 (38.2%) of 76 patients measured had positive antithyroglobulin (ATG) titers, whereas 65 (87%) of 75 patients measured had positive antimicrosomal (AM) titers. Seventy (55%) patients were evaluated with either a technetium or 131I thyroid scan. There was a heterogeneous pattern to the scan in 75% of these patients. Niney-one (71%) patients were initially treated with thyroid suppression. However, 27 (21%) required thyroidectomy for initial management. Ultimately, 60% required thyroidectomy and 37% required none. The major indication for surgical intervention was the presence of a dominant mass in 40 (52%) of 77 patients. Only 17 (13%) patients were found to have thyroid cancer concomitant with HT and 3 (2 %) had lymphoma with HT. The incidence of minimal (occult) cancer in a study of 100 consecutive autopsies at this institution was 13%. We believe that these data suggest that the association of HT with thyroid cancer is relative, at best. It will be necessary to prospectively follow both a large group of patients with HT and a control group of patients without HT for the incidence of thyroid cancer in each before this issue can be appropriately addressed.
has a distinct prevalence in women [1] . There appears to be a clear association between HT and lymphoproliferative disorders including lymphomas of the thyroid [2, 3] . However, the relationship between HT and thyroid carcinoma remains unclear. This remains true despite recent evidence to support the view that HT is a predisposing factor in the development of thyroid carcinoma [4] . Dailey et al. were the first to report a significant relationship between HT and thyroid carcinoma [5] . Subsequently, there has been considerable controversy over the accuracy of that finding with reports of incidences of thyroid carcinoma coexisting with HT ranging from 1% to 23% [6] [7] [8] [9] [10] [11] [12] [13] [14] . It is hypothesized that HT can be attributed to an inherited isolated defect in immunoregulation in which there is an organspecific defect in suppressor T-cell function [15, 16] . Since such a defect will also adversely affect immune surveillance, it remains possible that, given this inherited genetic disposition, a patient susceptible to thyroiditis may also be more susceptible to the growth and development of a thyroid neoplasm. Moreover, in HT there is an inhibition of the production of iodinated organic compounds in the glands of these patients. Consequently, there is a reduction in the production of thyroxine or triiodothyronine and this course of events stimulates the feedback of increased secretion of TSH [1] . It is argued, therefore, that the chronic stimulation of the thyroid by elevated levels of TSH may, in addition to inducing goiter formation, initiate or promote the growth of thyroid neoplasms.
The purpose of this retrospective study was to further evaluate the relationship between HT and thyroid cancer in our clinical experience and to determine whether the incidence of coexistent HT in thyroid cancer was, indeed, significantly higher than the incidence of coexistent HT in benign thyroid disease.
Methods
The pathology reports for all operative thyroidectomy specimens obtained at the University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A., over a 10-year-period beginning in January, 1975 and ending in December, 1985 were retrospectively reviewed. During this 10-year interval, 809 pathologic diagnoses were recorded for 816 thyroidectomy specimens submitted for pathologic evaluation. This data resulted from the management of 793 patients with thyroid disorders or clinical findings pertaining to the thyroid for which some form o f thyroidectomy(ies) was indicated. The histologic criteria used to make the diagnosis of HT included diffuse lymphoplasmacytic infiltration (Figs. 1, 2 ), germinal centers (Fig. 2) , enlarged epithelial cells with large nuclei and eosinophilic cytoplasm (Askanazy or H~irthle cells), fibrosis, distorted architecture, and small follicles depleted of thyroglobulin (Fig. 3) . Review of the pathologic description of the microscopic findings was meticulous in order to distinguish between cases of nonspecific thyroiditis and/or focal thyroiditis associated with thyroid cancer. However, ultimately, the pathological diagnosis was accepted as that recorded on the final pathology report.
During a concurrent time interval, 228 patients were identified by the Medical Records department of the University Hospital as having been coded with the diagnosis of HT. The medical records of 180 of these were available for review. One hundred and twenty-eight patients satisfied our criteria for the diagnosis of HT. These criteria included: hypothyroidism associated with a thyroid goiter; positive thyroid antithyroglobulin (ATG) and/or antimicrosomal (AM) antibodies associated with a thyroid mass or hypothyroidism, or classic pathologic findings of HT in the surgical specimen if a thyroidectomy was performed. Differences between frequency distributions observed were tested for using the chi-square test for independent samples [17] : P -< 0.05 was accepted as statistically significant. 
Results

Pathology Review
Seven hundred and ninety-three patients underwent 816 ~ thyroidectomies. These 816 thyroidectomies were comprised of 120 (14.7%) total thyroidectomies, 20 (2.5%) near total thyroidectomies, 41 (5.0%) completion thyroidectomies, 226 (27.7%) subtotal thyroidectomies, 399 (48.9%) lobectomies and/or isthmusectomies, and 10 (1.2%) nodulectomies (Table 1) . Eight hundred and nine pathologic diagnoses were reported based on the pathologic evaluation of the above thyroidectomy specimens. One hundred and ninety-five (24%) of 809 were thyroid carcinomas, 165 (84.6%) of which were well-differentiated thyroid carcinomas (Table 2 ). There were 10 (5.1%) lymphomas of the thyroid, 9 (4.6%) pure medullary thyroid carcinomas, 4 (2.1%) anaplastic or undifferentiated thyroid carcinomas as well as 3 squamous cell thyroid carcinomas, and 2 cases each of mixed medullary/papillary and metastatic thyroid carcinomas, respectively. A diagnosis of either HT or chronic lymphocytic thyroiditis (CLT) was made either individually or concurrently with another diagnosis in 147 (18.2%) of 809 pathologic cases reviewed. Although it is possible to distinguish between HT and CLT based on strictly pathologic criteria (for example, the absence of Askanazy or HOrthle cells in the latter), for the purpose of (Table 3) . Four cases (9.3%) were due to thyroid lymphoma. On the other hand, a total of 104 (70.7%) of 147 cases of HT were associated with benign thyroid disease. This occurred in an enlarged thyroid gland with either a single thyroid nodule or multiple nodules in virtually all cases (Table 4) . Overall, HT was associated with 43 (22.1%) of 195 cases of thyroid cancer in this series, whereas HT was associated with 104 (16.9%) of 614 cases of benign thyroid disease in the series. There was no statistically significant difference between the frequency distribution of HT associated with thyroid carcinoma versus benign thyroid disease (p > 0.10).
To examine further the association of HT with concurrent well-differentiated thyroid carcinoma, it was observed that 30 (21.0%) of 143 papillary thyroid carcinomas were associated with concurrent HT. Furthermore, papillary thyroid carcinoma represented 70% of all the cases of HT diagnosed to be associated with thyroid carcinoma. Five (50%) of 10 follicular thyroid carcinomas were associated with HT. One (8.3%) of 12 Hfirthle cell thyroid carcinomas were similarly associated with HT. In comparison to these distributions for well-differentiated thyroid carcinoma, 4 (40%) of 10 lymphomas of the thyroid were associated with HT.
The incidence of thyroid nodules in this series was 184 (22.7%) of 809 cases. One hundred and sixty-five (89.7%) of 184 thyroid nodules were colloid, 8 (4.3%) of 184 were follicular. The remainder were either atypical, cellular, or nonspecific thyroid nodules, Only 3 (1.6%) of 184 thyroid nodules were observed to contain concomittant HT. It should be noted here that cases with nonencapsulated nodules found in glands with diffuse involvement demonstrating findings that were consistent with HT were simply considered to represent HT. The clinical diagnosis regarding metabolic status was noted in 126 patients. Seventy-four patients (58.7%) were noted to be euthyroid, 46 (36.5%) were noted to be hypothyroid, and 6 (4.8%) were noted to be hyperthyroid based on purely clinical criteria. This compared with thyroid function studies consistent with a euthyroid status in 53 (50%) of 106 patients, a hypothyroid status in 50 (47.2%), and a hyperthyroid status in 3 (2.8%) ( Table 5) .
Only 29 (37.2%) of 78 patients measured had positive serum antithyroglobulin antibodies, whereas 64 (82.1%) had positive serum antimicrosomal antibodies.
Seventy patients (55.6%) of 126 were evaluated with either a 99m technetium or 1311 thyroid scan. A heterogeneous scan was observed in 75% of those studied. Eleven (61%) of 18 patients, for which there was specific data, had increased uptake on thyroid scan. In 29 (44.6)% of 65 thyroid scans a nodule was identified. Twenty-three (79.3%) of 29 thyroid nodules on thyroid scan were cold, whereas 5 (17.2%) were hot and in one the functional status was not stated. The incidence of thyroid carcinoma was 6 (31.6%) of 19 cold nodules. Seven (36.8%) of 19 cold nodules were colloid nodules, 2 (10.5%) cold nodules were benign adenomas, and 2 (10.5%) cold nodules were lymphomas of the thyroid. There was no instance of thyroid carcinoma seen in a hot nodule in this group of patients. One (33.3%) of 3 hot nodules was a lymphoma of the thyroid and the remaining 2 hot nodules were benign thyroid lesions. Ninety-one (72.8%) of 125 patients were initially treated with thyroid replacement (TSH suppression). However, 27 (21.6%) patients required thyroidectomy (24 subtotal thyroidectomies and 3 total thyroidectomies) for the initial management of their HT. Ultimately, 77 (60.2%) of 128 patients with HT required thyroidectomy to successfully manage their thyroiditis. Fortysix (37%) of 124 patients required no surgical intervention and 4 (3.2%) underwent needle biopsy which either confirmed or established the diagnosis of HT ( Table 6 ).
The major indication for thyroidectomy in this group of patients was the presence of a dominant mass in 40 (51.9%) of 77 patients, 31% of which had thyroid carcinoma (Table 7) . Two (6.9%) of 29 patients with dominant masses as an indication for thyroidectomy had lymphoma of the thyroid and 18 (62%) with dominant masses as the indication for thyroidectomy had benign thyroid disease.
Ninety-six (75%) of 128 patients had HT as their sole diagnosis. There were 5 (3.9%) patients with findings consistent with Hashitoxicosis, however, 3 of these patients had past medical histories of Graves' disease and probably represented Graves' disease with concurrent HT. Five patients (3.9%) had goiters with hypothyroidism both clinically and biochemically as the sole criteria for their diagnosis. Two patients (1.6%) had HT associated with benign adenomas. Only 17 (13.3%) patients of this group of 128 were found to have thyroid carcinoma concomitant with their HT and 3 (2.3%) had lymphoma of the thyroid concomitant with their HT (Table 8 ). The incidence of minimal (occult) thyroid carcinoma in a study of 100 consecutive autopsies at this institution was 13% [18] .
Discussion
Endemic goiter is the most common thyroid disease today [19] . The addition of iodine to the diet has actually increased the incidence of Hashimoto's thyroiditis, which falls into the category of endemic goiter. This is supported by the observation that lymphocytes are not found in the thyroid glands of iodinedeficient endemic goiters. The introduction of iodine into the diet in an endemic area is, however, accompanied by increasing lymphocytic infiltration with the subsequent development of HT [19] . This response is apparently preconditioned in a certain portion of the population by an underlying inherited or acquired biochemical defect in the thyroid, thus, impairing organic iodine binding. These facts may well explain why HT is probably the most common cause of diffuse goiter in the United States with an incidence in autopsy specimens of 2% [20, 21] . Furthermore, the incidence of HT has been documented to be increasing with (100) qncludes patients with Graves' Disease (3), goiter and HT (5), and probable Hashitoxicosis (2).
the highest incidence occurring in women aged 20-39 years [22] . The above simply highlights the fact that the incidence of HT is much higher than is appreciated, largely because the majority of these patients remain asymptomatic or insufficiently symptomatic to seek medical advice. Therefore, the 128 patients reviewed in this series are believed to represent a highly select group of patients with problematic or symptomatic HT. As such, the 13% incidence of thyroid carcinoma in this group of patients with HT represents an overestimate of the frequency distribution of thyroid cancer occurring in HT. Regardless, this incidence is no greater than the incidence observed for minimal occult thyroid carcinoma in i00 consecutive autopsies performed at the University of Michigan Medical Center [18] .
The findings that only 2 patients from this series of 128 patients with HT had an associated benign adenoma and that the incidence of HT was observed to be only 2-5% in thyroidectomy specimens with either benign adenoma, multinodular goiter, or colloid nodules suggests that it may be misleading if this group is used as a control or comparison group to examine the incidence of HT in thyroid cancer versus benign thyroid disease. This is further suggested by the fact that the incidence of HT in all benign thyroid disease among the thyroidectomy specimens was 104 (17%) of 614. Consequently, using colloid nodules as an internal control for benign disease with which to compare the incidences of HT in cancer and benign thyroid disease as utilized by Ott et al. [4] may not be appropriate. However, this point will require further investigation.
Although Hashimoto's thyroiditis associated with thyroid cancer has been documented in 3 gifts with ages ranging from 10 to 14 years [23] , the finding of such a young patient in the female group perhaps deserves comment. The youngest patient was a 4-year-old gift who had juvenile onset diabetes mellitus, a negative family history and a negative past medical history for other autoimmune diseases. She was euthyroid at presentation with a bilateral, diffuse goiter and positive antimicrosomal antibodies. Initially, she received no treatment. However, because of the increasing size of her goiter, in the absence of any discrete mass or nodule, she was placed on thyroid medication. During a 9-year follow-up she became hypothyroid and remained on thyroid medication until she was lost to follow-up. This case is consistent with the clonal-selection theory of immunity and highlights the precariousness of depending on the selective unresponsiveness of T-lymphocytes (suppressor Tcell lymphocyte function) to maintain tolerance to "self" or autoantibodies [24] . Since the difference between the immune response in the fetus and the adult is merely quantitative, it is not unexpected that autoimmune disease can theoretically occur at any age.
Moreover, this patient with autoimmune disease involving her pancreas (islet cells) as well as her thyroid suggests that she should be carefully observed and screened for other organspecific autoimmune diseases elsewhere, for example, her adrenal cortex (Schmidt's syndrome). As suggested by Clark et al., this child would need to be watched and screened carefully for Addison's disease in order to prevent inadvertent adrenal crisis [25] .
It is apparent from this review that patients with HT who are at risk for harboring concurrent thyroid cancer are those who are found to have a cold or nonfunctioning thyroid nodule on 99m technetium or 131I scan or those who present with a dominant thyroid mass that is nonsuppressible on adequate TSH suppression. Thyroid carcinoma was found in 32% of all cold thyroid nodules and 31% of all dominant thyroid masses in this series. These findings agree with the observations made by others [25, 26] and are consistent with the incidence of thyroid carcinoma in most clinical settings when associated with a solitary cold nodule [27] [28] [29] . In addition to a thyroid scan, Clark et al. recommend obtaining an ultrasound of the thyroid in evaluating patients with HT with a thyroid mass since, in their experience, cystic nodules of the thyroid in patients with HT are rarely malignant and are most often successfully managed by percutaneous aspiration [30] .
The indications for thyroidectomy in this series included: a dominant mass (discrete, clinically suspicious thyroid nodule or mass), signs of compression on the trachea and/or esophagus, a diffusely enlarged thyroid that is increasing in size despite TSH suppression, the failure of a thyroid nodule to regress while on thyroid replacement, airway obstruction, or miscellaneous factors such as hyperthyroidism secondary to autonomous function or a cosmetically unattractive neck mass.
In the absence of any of these findings or the demonstration of a dominant or solitary cold nodule, the management of patients with HT should include careful follow-up after the patient is on a stable regimen of adequate thyroid replacement (TSH suppression).
We believe that this retrospective study of clinical and pathologic material does not support the hypothesis that HT is a predisposing factor for thyroid carcinoma. It is concluded that the association of HT with thyroid-carcinoma is relative, at best, and that it will be necessary to prospectively follow both large populations of patients with and without HT before this issue can be resolved. Soixante-dix patients (55%) ont eu une scintigraphie au technetium ou ~t 1'I 131: la thyroide 6tait h6t6rog~ne pour 75% d'entre eux. Quatre-vingt un patients (71%) ont eu une hormonoth6rapie suppressive en premier, alors que 27 (21%) ont eu une thyroidectomie premiere. Ult6-rieurement, 60% des patients ont 6t6 thyroidectomis6s. L'indication principale de la chirurgie 6tait la pr6sence d'une masse, trouv6e chez 40 (52%) des 77 patients. Seuls 17 (13%) patients avec une TH avaient un cancer simultan6 de la thyro~de; 3 (2%) avaient un lymphome associ6 ~t une TH. La fr6quence de cancer occulte dans une 6rude de 100 autopsies cons6cutives dans notre 6tablissement 6tait de 13%. Nous pensons que ces r6sultats sugg~rent que l'association TH cancer de la thyroide n'est que fortuite. I1 est n6cessaire de suivre prospectivement un grand nombre de patients, divis6s en 2 groupes, les uns avec TH, les autres sans, pour d6terminer avec pr6cision l'incidence de cancer dans chaque groupe avant de r6soudre ce probl6me.
R~sum~
Resumen
La tiroiditis de Hashimoto (TH) es una enfermedad autoinmune de la tiroides, asociada con bocio e hipotiroidismo. Aunque existe una clara relaci6n entre TH y linfomas de la tiroides, la relaci6n entre TH y c~incer tiroideo no aparece clara. Con el ffn de evaluar este asunto, hemos revisado en forma retrospectiva tanto los informes de patologia de todos los especfmenes de tiroidectomfa, asi como las historias clfnicas de los pacientes admitidos al Centro M6dico de la Universidad de Michigan, Ann Arbor, Michigan, con el diagn6stico de TH o de tiroiditis linfocftica cr6nica (TLC) en un perfodo de 10 afios (1975-1985) . Se registraron 809 diagn6sticos patol6gicos de 816 especimenes de tiroidectomia en 793 pacientes. Adem~is, se dispuso de 180 de 228 historias cl/nicas para revisi6n. $61o 128 pacientes satisficieron nuestros criterios para el diagn6stico de TH. TH o TLC fueron diagnosticadas en 147 (18.2%) de 809 de los especimenes tiroideos. La TH ocurri6 en forma concurrente con el c~incer tiroideo en 24% de todos los casos de TH, en tanto que la TH ocurri6 en forma concurrente con enfermedad benigna de la tiroides en 71% de la totalidad de los casos de TH en todos los especfmenes tiroideos. Se encontraron 111 (87%) mujeres y 17 (13%) hombres de 128 pacientes cuyas historias clinicas fueron revisadas: la edad promedio fue 49 -+ 14 afios. Noventa y ocho (77%) de los pacientes presentaban bocio y 57 (45%) presentaban masas tiroideas dominantes, de las cuales 38 (67%) eran n6dulos solitarios. Un paciente (0.8%) se present6 con parfilisis del nervio recurrente laringeo y 12 (9%) con compresi6n traqueal. $61o 29 (38.2%) de 76 pacientes investigados tenian titulos positivos de ATG, mientras 65 (87%) de 75 tenfan tftulos AM positivos. Setenta (55%) fueron evaluados mediante escanografia con tecnecio o con 131I; se observ6 un patr6n heterog6neo en la gamagrafia en 75% de ellos. Noventa y uno (71%) fueron tratados inicialmente con supresi6n tiroidea. Sin embargo, 27 (21%) requirieron tiroidectomfa en su manejo inicial. A1 final 60% requirieron tiroidectomfa y 37% no la requirieron. La indicaci6n mayor para intervenci6n quirtirgica fue |a presencia de una masa dominante en 40 (52%) de 77 pacientes. $61o 17 (13%) pacientes exhibieron cfincer tiroideo concomitante con TH y 3 (2%) presentaron linfoma con TH. La incidencia de cfincer minimo (oculto) en un estudio de 100 autopsias consecutivas en nuestra instituci6n fue 13%. Consideramos que estos datos sugieren que la relaci6n entre TH y c~ncer tiroideo es apenas relativa, en el mejor de los casos. Ser~i necesario hacer el seguimiento prospectivo de un grupo grande de pacientes con TH y de un grupo control sin TH para detectar la incidencia de c~incer tiroideo en cada grupo para poder enfocar en forma apropiada este asunto.
